Somatostatin: still a pharmaceutical defense weapon against post-ERCP pancreatitis? A 30-year story

Endoscopy. 2015 May;47(5):393-5. doi: 10.1055/s-0034-1391658. Epub 2015 Apr 24.

Author

Pier Alberto Testoni¹

Affiliation

¹ Gastroenterology and Gastrointestinal Endoscopy Division, Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute, Milan, Italy.

PMID: 25910006
DOI: 10.1055/s-0034-1391658

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cholangiopancreatography, Endoscopic Retrograde / adverse effects*
Female
Hormones / therapeutic use*
Humans
Male
Pancreatitis / prevention & control*
Somatostatin / therapeutic use*

Substances

Hormones
Somatostatin